These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3705006)

  • 21. Heparin-associated thrombocytopenia.
    Cines DB; Kaywin P; Bina M; Tomaski A; Schreiber AD
    N Engl J Med; 1980 Oct; 303(14):788-95. PubMed ID: 7412786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Heparin-induced thrombocytopenia and thrombosis with spinal ischemia--recovery of platelet count following change to low molecular weight heparin].
    Maurin N; Biniek R; Bohndorf K; Heintz B; Kierdorf H; Schulte-Bockholt A
    Vasa Suppl; 1991; 32():295-9. PubMed ID: 1663274
    [No Abstract]   [Full Text] [Related]  

  • 23. Heparin-associated thrombocytopenia and thrombosis: optimal therapy with ancrod.
    Cole CW; Fournier LM; Bormanis J
    Can J Surg; 1990 Jun; 33(3):207-10. PubMed ID: 2190683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin-induced thrombocytopenia with arterial thrombosis: an unusual case.
    Di Natale M; Fiusti R; Grassi M; Lai F; Corradi F
    Haematologica; 1995; 80(3):246-7. PubMed ID: 7672719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay.
    Bryant A; Low J; Austin S; Joseph JE
    Br J Haematol; 2008 Dec; 143(5):721-6. PubMed ID: 19036016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Heparin induced thrombocytopenia type II after the use of low-molecular weight heparin. Case report and review of the literature].
    Franke J; Schaeper O; Kayser R; Mahlfeld K
    Unfallchirurg; 2003 Jan; 106(1):77-81. PubMed ID: 12552397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations.
    Rhodes GR; Dixon RH; Silver D
    Surg Gynecol Obstet; 1973 Mar; 136(3):409-16. PubMed ID: 4688805
    [No Abstract]   [Full Text] [Related]  

  • 28. [Myocardial infarction and massive biventricular thrombosis during thrombocytopenia induced by pentosan polysulfate and heparin].
    Leclercq C; de Place C; Rioux C; Mabo P; Paillard F; Daubert JC
    Arch Mal Coeur Vaiss; 1990 Jan; 83(1):117-20. PubMed ID: 1689564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin induced thrombocytopenia: case reports and a prospective study.
    Romeril KR; Hickton CM; Hamer JW; Heaton DC
    N Z Med J; 1982 Apr; 95(706):267-9. PubMed ID: 6953369
    [No Abstract]   [Full Text] [Related]  

  • 30. [Severe early-onset thrombopenia induced by non-fractionated heparin: therapeutic trial with low molecular weight heparin].
    Grau E; Fontcuberta J; Martinez R; Latorre J; Felez J; Rutllant ML
    Nouv Rev Fr Hematol (1978); 1985; 27(6):385-7. PubMed ID: 4094896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up.
    Mattioli AV; Bonetti L; Sternieri S; Mattioli G
    Ital Heart J; 2000 Jan; 1(1):39-42. PubMed ID: 10868921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical presentation of heparin-induced thrombocytopenia.
    Warkentin TE
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):9-16; discussion 35-6. PubMed ID: 9855179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin-induced thrombocytopenia.
    Kelton JG; Levine MN
    Semin Thromb Hemost; 1986 Jan; 12(1):59-62. PubMed ID: 3961506
    [No Abstract]   [Full Text] [Related]  

  • 34. The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases.
    Refaai MA; Van Cott EM; Laposata M
    Am J Clin Pathol; 2003 Apr; 119(4):497-504. PubMed ID: 12710122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heparin-induced thrombocytopenia in patients and prevention with low molecular weight heparin].
    Kormanová K; Krska Z; Trca S; Pesková M; Korínková P
    Sb Lek; 2001; 102(3):419-25. PubMed ID: 12092129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Heparin-associated thrombocytopenia caused by low-molecular-weight heparin].
    Köninger J; Greinacher A; Müller-Beissenhirtz W; Strosche H
    Unfallchirurg; 1995 Jan; 98(1):49-51. PubMed ID: 7886465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher optical density of an antigen assay predicts thrombosis in patients with heparin-induced thrombocytopenia.
    Altuntas F; Matevosyan K; Burner J; Shen YM; Sarode R
    Eur J Haematol; 2008 May; 80(5):429-35. PubMed ID: 18208574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of anti-PF4/heparin antibodies and the HIT syndrome in cardiovascular medicine.
    Mattioli AV
    Semin Thromb Hemost; 2004 Jun; 30(3):291-5. PubMed ID: 15282651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin-induced thrombocytopenia: use of indirect immunofluorescence.
    Silberman S; Kovarik P
    Ann Clin Lab Sci; 1987; 17(2):106-10. PubMed ID: 3555279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of fraxiparin for the prevention and treatment of thromboembolism in patients with heparin-induced thrombocytopenia].
    Barkagan ZS
    Ter Arkh; 1993; 65(10):77-82. PubMed ID: 8296242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.